Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nanobiotix (NBTX) Total Debt (2018 - 2025)

Nanobiotix has reported Total Debt over the past 8 years, most recently at $111.0 million for Q4 2025.

  • For Q4 2025, Total Debt rose 103.99% year-over-year to $111.0 million; the TTM value through Dec 2025 reached $111.0 million, up 103.99%, while the annual FY2025 figure was $111.0 million, 103.99% up from the prior year.
  • Total Debt for Q4 2025 was $111.0 million at Nanobiotix, up from $58.0 million in the prior quarter.
  • Over five years, Total Debt peaked at $111.0 million in Q4 2025 and troughed at $32.7 million in Q4 2022.
  • A 5-year average of $58.4 million and a median of $54.4 million in 2024 define the central range for Total Debt.
  • Biggest five-year swings in Total Debt: crashed 37.87% in 2022 and later soared 103.99% in 2025.
  • Year by year, Total Debt stood at $52.6 million in 2021, then crashed by 37.87% to $32.7 million in 2022, then surged by 66.33% to $54.4 million in 2023, then decreased by 0.02% to $54.4 million in 2024, then soared by 103.99% to $111.0 million in 2025.
  • Business Quant data shows Total Debt for NBTX at $111.0 million in Q4 2025, $58.0 million in Q2 2025, and $54.4 million in Q4 2024.